Baricitinib Development as a Lupus Treatment Discontinued
January 28, 2022
The Lupus Research Alliance is disappointed that the Phase 3 development program of OLUMIANT® (baricitinib) as a...
Olumiant
Lupus Research Alliance Encouraged by Lilly Looking at Potential Lupus Drug for COVID-19
April 23, 2020
The Lupus Research Alliance is pleased to share that Eli Lilly and Company entered into an agreement...
Stelara® and Olumiant® Considered Promising by Lupus Expert
February 19, 2019
In Healio Rheumatology, Dr. Gregg Silverman, professor of medicine and pathology at NYU School of Medicine, provided...